期刊文献+

高效抗反转录病毒治疗对HIV阳性孕妇的影响 被引量:4

Influence of Highly Active Antiretroviral Therapy on HIV-infected Pregnant Patients
暂未订购
导出
摘要 目的探讨抗反逆转录病毒治疗(HAART)对HIV阳性孕妇的影响。方法选取2005年1月~2010年12月在我院行母婴阻断接受HAART的HIV阳性孕妇107例为研究组,随机选取同期在广州市某医院产科HIV阴性孕妇135例为对照组。对孕妇的肝功能、血常规、生化指标等临床资料进行回顾性分析。根据接受HAART治疗时间不同分为HAART治疗1组(〈12w)、2组(12~36w)及3组(≥36w),比较相关指标在研究组与对照组的差别。结果研究组的WBC均数为7.39±2.20×109/L、RBC均数为3.08±0.49×1012/L、Hb均数为101.87±12.75g/L、GLB均数为30.68±4.86g/L、空腹Glu均数为4.15±0.91mmol/L与对照组比较,差异有显著性意义(P〈0.05);研究组AST升高等级与对照组比较,差异有显著性意义(χ2=6.29,P〈0.05);PLT、TBil、ALT等级、TG、TC等指标差异无显著性意义(P〉0.05)。根据接受HAART时间对研究组再分3组,3组组间差异有统计学意义(P〉0.05)。1组与2组比较,WBC、RBC差异有统计学意义(P〉0.05);1组与3组比较,RBC、Hb、GLB差异有统计学意义(P〉0.05);2组与3组比较,Hb、GLB差异有统计学意义(P〉0.05)。根据是否感染肝炎病毒对所有观察案例进行分组,感染组与非感染者比较,肝功能分级差异有显著性意义(χ2=13.51,P〈0.01)。结论短期应用HAART药物对HIV阳性孕妇是安全的,在营养和肝功能没有明显的影响。接受HAART〈12w的HIV阳性孕妇应注意监测血常规,及时调整治疗方案及对症处理。 Objective To investigate influence of highly active antiretroviral therapy (HAART)on HIVinfected pregnant women by retrospectiving study method.Methods 115 pregnant women identifiedwith HIV infected and their newborn babies were analyzed as study group in our hospital from January 2005 to December 2010. All the pregnants had accepted antiretroviral drugs for blockade of HIV moth-er-to-child transmission. 135 HIV negative pregnant women and their newborns were chosen at random in a hospital of Guangzhou city as control group. Based on the time of HAART,patients in study groupwere divided into three groups between which the differences were analyzed.Results There were statistic significant differences between WBC, RBE, Hb, GLB, AST and CD4 count of study group and control group (P〈0.05).While there were no significant differences between their hemoglobin, albumin, glucose, total cholesterOl and triglyceride (P〉0.05).In study group,there was a statistic difference betweenWBC,RBC of group 1 and group 2, so were RBC, Hb, GLB of group 1 and group 3 and Hb, GLB of group 1 and group 3. All cases were divided into two groups according to hepatitis virus-infected ornot. Statistic difference of liver function level in the two groups was found. Conclusion Short-time HAART is safe to HIV-infected pregnant women with no influence on nutritional state and liver function. In cases which had accepted HAART less than 12 weeks, regular blood test and prompt and relative treatment should be given.
出处 《现代诊断与治疗》 CAS 2013年第3期483-485,共3页 Modern Diagnosis and Treatment
基金 广东省医学科研基金(A2009549) 广州市医药卫生科技项目(2008-YB-076)
关键词 HIV 高效抗反转录病毒治疗 孕妇 影响 副作用 HIV Highly active antiretroviral therapy Pregnant woman Influence Adverse effect
  • 相关文献

参考文献9

  • 1European collaborative study.Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy [J].Clin Infect Dis,2005,40(5):458 -465.
  • 2MagderL S, Mofcnson L,Paul M E,et al.Risk factors for inutero and intrapartum transmission of HIVJ].J Acquit Immune Defic Syndr, 2005,38(1) : 394-402.
  • 3乐杰.妇产科学[M].第6版.北京:人民卫生出版社,2005.262.
  • 4AIDS Clinical Trials Group Table of grading severity of adult ad- verse experience[R].Rockville, M D: US division of AIDS,National institute of Allergy and Infectious Diseases,1996.
  • 5Morcroft A,Krk O,Barton SE,et al.Anaemia is an dependent predi- etive marker for clinical prognosis in HIV-infected patienis from across Europe [J ].AIDS.1999,13(6):943-50.
  • 6Carr A,Cooper DA.Adverse effects of antiretroviral therapy [J]. Lancet,2000,356(9239) : 1423-1430.
  • 7吴丽娟.高效抗逆转录病毒治疗对艾滋病患者血常规的影响[D].浙江大学硕士学位论文.2007.
  • 8Bica I, McGovern B, Dhar R,et al.Increasing mortality due to end- stage liver disease in patients with human immunodef i ciency virus in- fection [ J ].Clin Infect Dis,2001,32 ( 11 ): 492 -4971.
  • 9Soriano V, Rodrigue-Rosado R,Garcia-Samaniego J,et al. Impact of chronic viral liver disease due to hepatitis virus as cause of hospital admission and death in H IV-infected drug user[J].Eur J Epidemiol,1999,15(70):1-41.

共引文献705

同被引文献24

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部